GTBP
#4624
GT Biopharma, Inc. - Common Stock
6.5 0 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.27%
Variación mensual
-37.98%
Variación en los últimos 6 meses
+1656.76%
Cambio anual
+828.57%
Cierres anteriores
6.7 2
Open
7.5 0
Mínimo
6.3 3
Máximo
7.5 0
Financials
- Market Capitalization 11.73 M
- Employee 1
- Founded N/A
- CEO N/A
- Website www.gtbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG000DHJ738
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4588 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 1.39 USD | -2.80% | -8.55% | -39.83% | -55.73% | 13.14 M USD | ||
| 4590 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 8.04 USD | -8.74% | -12.61% | -27.63% | +37.44% | 13.02 M USD | ||
| 4626 |  PASG Passage Bio, Inc. - Common Stock | 3.64 USD | -20.00% | -9.45% | -22.55% | -58.82% | 11.71 M USD | ||
| 4629 |  INAB IN8bio, Inc. - Common Stock | 1.18 USD | -4.07% | -14.49% | +8.26% | -29.34% | 11.63 M USD |